Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 11Terminated 3Withdrawn 2Unknown 2Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Classical hematology 1

Conditions

Pain, Intractable 1Neoplasms 1Mucositis 1Leukemia 1Chronic Pain 1Cancer Pain 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1

Interventions

E 7107 2Carboplatin 2palbociclib 1gedatolisib 1eniluracil 1dabrafenib 1abarelix 1Topotecan 1Standard of Care 1Radionuclide Imaging 1Radiofrequency Ablation 1Practice Guidelines as Topic 1Positron-Emission Tomography 1Passive Cutaneous Anaphylaxis 1Paclitaxel 1NUC-1031 1Morphine 1Methadone 1Maltose 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1KB004 1Injections 1Infusions, Parenteral 1Hyperthermic Intraperitoneal Chemotherapy 1Hydromorphone 1Gemcitabine 1Fluorodeoxyglucose F18 1Flucytosine 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Neoplasms × Morphine × Clear all
NCT06940570 2025-10-23

MATCH

University of Texas Southwestern Medical Center

Phase 3 Suspended
60 enrolled
Classical hematologyOtherOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Leukemia, Neoplasms, Pain, Intractable, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡